$439M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | IVZ Invesco Db Commdy Indx Trck | 1.1M | +0.0% | $28M | 6.4% |
| 2 | ABIVAX SA Abivax Sa | 113,031 | −0.2% | $15M | 3.4% |
| 3 | RVMD Revolution Medicines Inc | 66,983 | −3.4% | $13M | 2.9% |
| 4 | DFTX Definium Therapeutics Inc | 242,884 | +30.7% | $11M | 2.6% |
| 5 | IMVT Immunovant Inc | 277,873 | +23.4% | $11M | 2.4% |
| 6 | PRAX Praxis Precision Medicines I | 30,210 | +14.8% | $10M | 2.3% |
| 7 | RLAY Relay Therapeutics Inc | 506,235 | +20.0% | $9M | 2.2% |
| 8 | ALKS Alkermes Plc | 179,256 | +144.9% | $9M | 2.1% |
| 9 | PCVX Vaxcyte Inc | 149,739 | +20.1% | $9M | 2.0% |
| 10 | TNGX Tango Therapeutics Inc | 260,070 | +149.6% | $8M | 1.9% |
| 11 | LQDA Liquidia Corporation | 97,896 | −1.9% | $8M | 1.8% |
| 12 | COGT Cogent Biosciences Inc | 188,780 | −4.2% | $7M | 1.7% |
| 13 | GPCR Structure Therapeutics Inc | 130,784 | +5.5% | $7M | 1.6% |
| 14 | ELVN Enliven Therapeutics Inc | 137,866 | +88.6% | $7M | 1.6% |
| 15 | AMLX Amylyx Pharmaceuticals Inc | 386,080 | +9.7% | $7M | 1.6% |
| 16 | SYRE Spyre Therapeutics Inc | 77,807 | −46.8% | $7M | 1.6% |
| 17 | LBRX Lb Pharmaceuticals Inc | 211,511 | +21.8% | $7M | 1.6% |
| 18 | CYTK Cytokinetics Inc | 78,003 | +33.0% | $7M | 1.5% |
| 19 | CCCC C4 Therapeutics Inc | 1.3M | — | $6M | 1.4% |
| 20 | TYRA Tyra Biosciences Inc | 184,774 | +40.7% | $6M | 1.3% |
| 21 | ALMS Alumis Inc | 199,968 | +77.1% | $6M | 1.3% |
| 22 | PHVS Pharvaris N V | 160,494 | +64.0% | $6M | 1.3% |
| 23 | TARS Tarsus Pharmaceuticals Inc | 87,060 | +65.9% | $5M | 1.2% |
| 24 | CMPS Compass Pathways Plc | 371,120 | +1.9% | $5M | 1.2% |
| 25 | DNTH Dianthus Therapeutics Inc | 51,125 | +43.7% | $5M | 1.1% |
| 26 | NRIX Nurix Therapeutics Inc | 203,739 | −10.1% | $5M | 1.1% |
| 27 | AXSM Axsome Therapeutics Inc. | 20,183 | −1.2% | $5M | 1.1% |
| 28 | TVTX Travere Therapeutics Inc | 86,233 | +137.4% | $5M | 1.1% |
| 29 | VERA Vera Therapeutics Inc | 105,907 | +53.0% | $5M | 1.0% |
| 30 | NVDA Nvidia Corporation | 21,792 | −2.8% | $4M | 1.0% |
| 31 | GHRS Gh Research Plc | 158,770 | −25.5% | $4M | 1.0% |
| 32 | PALI Palisade Bio Inc | 2.0M | +0.6% | $4M | 1.0% |
| 33 | ARGX Argenx Se | 4,561 | −7.3% | $4M | 1.0% |
| 34 | MAZE Maze Therapeutics Inc | 136,572 | +36.8% | $4M | 0.9% |
| 35 | OCUL Ocular Therapeutix Inc | 408,534 | −7.5% | $4M | 0.9% |
| 36 | ORKA Oruka Therapeutics Inc | 41,902 | −46.9% | $4M | 0.9% |
| 37 | DYN Dyne Therapeutics Inc | 171,961 | −6.0% | $4M | 0.9% |
| 38 | EWTX Edgewise Therapeutics Inc | 90,996 | −1.0% | $4M | 0.8% |
| 39 | MLTX Moonlake Immunotherapeutics | 187,946 | −3.1% | $4M | 0.8% |
| 40 | INSM Insmed Inc | 31,256 | +28.5% | $3M | 0.8% |
| 41 | CLDX Celldex Therapeutics Inc New | 86,964 | −2.7% | $3M | 0.7% |
| 42 | AMZN Amazon Com Inc | 13,397 | −40.2% | $3M | 0.7% |
| 43 | IVA Inventiva Sa | 831,442 | +35.0% | $3M | 0.7% |
| 44 | TLN Talen Energy Corp | 8,148 | +161.3% | $3M | 0.7% |
| 45 | RLMD Relmada Therapeutics Inc | 445,799 | — | $3M | 0.7% |
| 46 | PTGX Protagonist Therapeutics Inc | 24,460 | −27.7% | $3M | 0.7% |
| 47 | ERAS Erasca Inc | 160,328 | −11.5% | $3M | 0.7% |
| 48 | VRDN Viridian Therapeutics Inc | 159,885 | +19.1% | $3M | 0.7% |
| 49 | HPE Hewlett Packard Enterprise C | 59,081 | −34.3% | $3M | 0.6% |
| 50 | MLYS Mineralys Therapeutics Inc | 86,085 | +84.0% | $2M | 0.5% |